• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    GCC Genetic Testing Market

    ID: MRFR/LS/43268-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    GCC Genetic Testing Market Research Report By Type (Molecular Genetic Tests/ DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, Others), By Type (Prescribed Genetic Testing, Direct-to-Consumer Genetic Testing) and By Application (Reproductive Health, Cancer Screening Ancestry, Predictive and Pre-Symptomatic Testing, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    GCC Genetic Testing Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    GCC Genetic Testing Market Summary

    The GCC Genetic Testing market is projected to grow significantly from 750 USD Million in 2024 to 2500 USD Million by 2035.

    Key Market Trends & Highlights

    GCC Genetic Testing Key Trends and Highlights

    • The GCC Genetic Testing market is valued at 750 USD Million in 2024.
    • By 2035, the market is expected to reach 2500 USD Million, indicating robust growth.
    • The market is anticipated to grow at a CAGR of 11.57% from 2025 to 2035.
    • Growing adoption of genetic testing due to increasing awareness of personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 750 (USD Million)
    2035 Market Size 2500 (USD Million)
    CAGR (2025 - 2035) 11.57%

    Major Players

    Saudi Aramco (SA), Qatar Petroleum (QA), Emirates National Oil Company (AE), SABIC (SA), Oman Oil Company (OM), Kuwait Petroleum Corporation (KW), Bahrain Petroleum Company (BH), Abu Dhabi National Oil Company (AE)

    GCC Genetic Testing Market Trends

    The GCC Genetic Testing Market is witnessing significant growth driven by increasing awareness of genetic disorders and the rising prevalence of chronic diseases within the region. With a growing emphasis on personalized medicine, healthcare providers in GCC countries are increasingly integrating genetic testing services into clinical practice, enabling more targeted treatment plans. This evolution is further propelling investments in advanced laboratory technology and infrastructure . Opportunities to be explored include the growing demand for prenatal and carrier screening tests among expectant parents, driven by cultural awareness of hereditary diseases prevalent in the region.

    Moreover, the adoption of telemedicine has opened avenues for genetic counseling, making it more convenient for patients to access expert advice without needing to travel. The GCC's strategic initiatives to promote genomic research and data collection, such as the UAE’s National Genome Project, highlight a strong commitment to advancing genetic testing capabilities and fostering innovation within the region. Trends in recent times show an increase in partnerships between public and private sectors to develop genetic research studies that address local health priorities.

    Additionally, there is a noticeable shift toward integrating artificial intelligence into genetic data analysis, enhancing the efficiency and accuracy of genetic testing processes. As governments in the GCC prioritize precision medicine and healthy lifestyles, the genetic testing market is poised for further expansion, supporting the overall enhancement of public health and personalized treatment options within the region.

    GCC Genetic Testing Market Drivers

    Market Segment Insights

    GCC Genetic Testing Market Segment Insights

    GCC Genetic Testing Market Segment Insights

    Genetic Testing Market Type Insights

    Genetic Testing Market Type Insights

    The GCC Genetic Testing Market has showcased significant evolution in recent years, with the Type segment emerging as a critical area of focus. This segment is prominently categorized into various types of tests, which include Molecular Genetic Tests/DNA Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests, and others. Molecular genetic tests, often referred to simply as DNA tests, play a vital role in identifying specific genes, proteins, or metabolites related to genetic disorders. Their importance cannot be understated, as they are frequently utilized in both clinical diagnosis and personal genomics, reading genetic blueprints that guide treatment plans.

    Additionally, Chromosomal genetic tests are instrumental in identifying chromosomal abnormalities, which can lead to severe health issues. This class of tests allows for insight into conditions such as Down syndrome and various other genetic abnormalities, leading to preventative strategies in health management.

    On the other hand, Biochemical genetic tests are essential in diagnosing metabolic disorders, tying closely to newborn screening programs that many GCC nations have successfully implemented. These screenings are crucial for early intervention, significantly improving health outcomes for affected individuals. Collectively, the other tests within this segment tend to cover a broader aspect of genetic evaluations, providing valuable data that may not fit neatly into the aforementioned categories but are nonetheless critical for comprehensive genetic profiling and risk assessment.

    As healthcare continues to advance and embrace personalized medicine, the Type segment of the GCC Genetic Testing Market is poised to grow, driven by increasing public awareness, technological advancements in testing methodologies, and a supportive regulatory environment in the region, which is currently embracing innovation in healthcare solutions.

    Genetic Testing Market Type Insights

    Genetic Testing Market Type Insights

    The GCC Genetic Testing Market is experiencing notable growth, driven by the expanding relevance of genetic testing in healthcare. Among the types of genetic testing, Prescribed Genetic Testing holds a significant position as it is often utilized by healthcare professionals to diagnose hereditary conditions and guide treatment decisions based on individual genetic profiles. This type of testing is crucial in precision medicine, allowing for tailored therapies that improve patient outcomes.

    On the other hand, Direct-to-Consumer Genetic Testing is rapidly gaining traction within the region, appealing to individuals seeking insights into their ancestry, health risks, and genetic predispositions without the need for a healthcare provider’s prescription. This segment promotes consumer awareness and engagement in personal health, allowing individuals to take proactive steps. The growing popularity of at-home testing kits reflects a shift towards personalized healthcare and preventive measures. Overall, the market dynamics reveal a dual approach, where prescribed testing plays a vital role in clinical settings, while direct-to-consumer options democratize genetic awareness, leading to a more informed public.

    The GCC region's investment in healthcare innovation and rising demand for personalized medical solutions will further enhance the evolution of these genetic testing types in the coming years.

    Genetic Testing Market Application Insights

    Genetic Testing Market Application Insights

    The Application segment of the GCC Genetic Testing Market is expanding rapidly as healthcare systems increasingly embrace personalized medicine. This segment encapsulates a range of essential applications, including Reproductive Health, where genetic testing assists in identifying potential hereditary conditions and optimizing family planning. Cancer Screening is gaining traction due to the rising prevalence of genetic predispositions to various cancers, driving demand for early detection and targeted therapies.

    Ancestry testing experiences strong interest as consumers seek to uncover their genetic heritage and connect to cultural roots, fostering a sense of identity.Predictive and Pre-Symptomatic Testing offers individuals insights into their genetic risk for diseases, encouraging proactive health management. The GCC region sees significant investment in genomic infrastructure and research, positioning the market for growth as healthcare policies increasingly support innovation in genetic testing.

    With a rising focus on personalized healthcare and a well-informed populace, the Application segment of the GCC Genetic Testing Market is poised for remarkable advancements and adoption, responding to both regional healthcare priorities and global trends in genetics.

    Get more detailed insights about GCC Genetic Testing Market Research Report - Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The GCC Genetic Testing Market is experiencing significant growth driven by advancements in genomic research, increased chronic disease prevalence, and a rising emphasis on personalized medicine. The competitive landscape is characterized by a mix of established companies and emerging players who are vying for market share. These companies are focusing on innovative services, technological advancements, and strategic partnerships to enhance their offerings and improve customer reach. With the regulatory environment evolving in the region, companies are continuously adapting their strategies to meet both local and international standards, which adds a layer of complexity to the competitive scene.

    The increasing awareness among consumers regarding genetic testing for risk assessment and their proactive stance towards healthcare are contributing to a positive growth trajectory within this market.Genetic Technologies Limited has positioned itself strategically within the GCC Genetic Testing Market through its innovative approaches genetic testing solutions. The company has achieved a notable presence by emphasizing the quality and reliability of its tests, which cater to various genetic disorders and risk assessments. Its strengths lie in its strong research and development capabilities that allow for cutting-edge product offerings, thus meeting the growing demand for personalized healthcare solutions within the region.

    As a result, Genetic Technologies Limited has successfully forged partnerships with local healthcare providers and institutions, thereby enhancing its market footprint and brand recognition in the GCC states.Roche Diagnostics stands out in the GCC Genetic Testing Market by leveraging its extensive portfolio of innovative diagnostic solutions and technologies. The company offers a range of key products and services that include advanced genetic tests aimed at oncology, prenatal testing, and hereditary conditions.

    Roche Diagnostics has established a strong market presence due to its commitment to research and development, alongside strategic mergers and acquisitions that contribute to expanding its capabilities in genetic testing. The company's strengths are further anchored in its integration of cutting-edge technology solutions, enabling healthcare providers in the GCC region to offer accurate and timely genetic testing services. Roche Diagnostics also invests in local collaborations and educational initiatives, which bolster its reputation as a leader in genetic diagnostics while ensuring its products align with the specific health needs of the population in the GCC.

    Key Companies in the GCC Genetic Testing Market market include

    Industry Developments

    The GCC Genetic Testing Market has seen significant developments recently, especially with . In October 2023, Roche Diagnostics announced an expanded partnership to enhance genetic testing services across the Gulf states, focusing on precision medicine. Furthermore, Natera launched a new non-invasive prenatal testing (NIPT) service in the region, aiming to improve maternal and fetal health outcomes.Mergers and acquisitions remain an active aspect of this market, with BioReference Laboratories acquiring a regional competitor in February 2023, strategizing to broaden its testing capabilities in the GCC.

    In March 2023, Quest Diagnostics also completed the acquisition of a local laboratory to enhance its genetic testing portfolio. The market is experiencing growth, with an estimated valuation increase due to rising health awareness and demand for personalized medicine in countries like Saudi Arabia and the UAE. Developments in the regulatory landscape and government investments in healthcare technology have further bolstered the sector, making it an essential area for innovation and investment. The ongoing collaborations and advancements reflect the GCC's commitment to becoming a hub for genetic testing services and precision health.

    Market Segmentation

    Outlook

    • Reproductive Health
    • Cancer ScreeningAncestry
    • Predictive and Pre-Symptomatic Testing
    • Others

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 0.56(USD Billion)
    MARKET SIZE 2024 1.2(USD Billion)
    MARKET SIZE 2035 3.95(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 11.459% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Genetic Technologies Limited, Roche Diagnostics, BioReference Laboratories, Laboratory Corporation of America Holdings, Natera, Agilent Technologies, Myriad Genetics, Quest Diagnostics, 23andMe, Fulgent Genetics, Thermo Fisher Scientific, Illumina, Sema4, GeneDx
    SEGMENTS COVERED Type, Type, Application
    KEY MARKET OPPORTUNITIES Increased chronic disease prevalence, Growing preventive healthcare awareness, Expansion of telemedicine services, Rising interest in personalized medicine, Advancements in genetic testing technologies
    KEY MARKET DYNAMICS rising prevalence of genetic disorders, increasing healthcare expenditure, growing awareness and acceptance, technological advancements in testing, regulatory frameworks and policies
    COUNTRIES COVERED GCC

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the expected market size of the GCC Genetic Testing Market in 2024?

    The GCC Genetic Testing Market is expected to be valued at 1.2 billion USD in 2024.

    What will be the market value of the GCC Genetic Testing Market by 2035?

    By 2035, the GCC Genetic Testing Market is projected to reach a value of 3.95 billion USD.

    What is the expected CAGR for the GCC Genetic Testing Market from 2025 to 2035?

    The GCC Genetic Testing Market is expected to grow at a CAGR of 11.459% from 2025 to 2035.

    Which type of genetic testing is expected to dominate the market in 2024?

    Molecular Genetic Tests/DNA Tests are expected to dominate the market with a value of 0.48 billion USD in 2024.

    What will be the market size for Chromosomal Genetic Tests in 2035?

    The market for Chromosomal Genetic Tests is projected to reach 1.17 billion USD by 2035.

    What are some key players in the GCC Genetic Testing Market?

    Major players in the market include Genetic Technologies Limited, Roche Diagnostics, and Illumina among others.

    How much is the Biochemical Genetic Tests segment expected to grow by 2035?

    The Biochemical Genetic Tests segment is expected to grow to 0.85 billion USD by 2035.

    What opportunities are driving growth in the GCC Genetic Testing Market?

    The increasing awareness of genetic disorders and advancements in technology are key growth drivers in the market.

    How much is the Others segment of the market valued at in 2024?

    The Others segment of the GCC Genetic Testing Market is valued at 0.14 billion USD in 2024.

    What challenges are currently facing the GCC Genetic Testing Market?

    Regulatory hurdles and ethical concerns are among the challenges facing the GCC Genetic Testing Market.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. GCC Genetic Testing Market, BY Type (USD Billion)
    45. Prescribed Genetic Testing
    46. Direct-to-Consumer Genetic Testing
    47. GCC Genetic Testing Market, BY Application (USD Billion)
    48. Reproductive Health
    49. Cancer ScreeningAncestry
    50. Predictive and Pre-Symptomatic Testing
    51. Others
    52. Competitive Landscape
    53. Overview
    54. Competitive Analysis
    55. Market share Analysis
    56. Major Growth Strategy in the Genetic Testing Market
    57. Competitive Benchmarking
    58. Leading Players in Terms of Number of Developments in the Genetic Testing Market
    59. Key developments and growth strategies
    60. New Product Launch/Service Deployment
    61. Merger & Acquisitions
    62. Joint Ventures
    63. Major Players Financial Matrix
    64. Sales and Operating Income
    65. Major Players R&D Expenditure. 2023
    66. Company Profiles
    67. Genetic Technologies Limited
    68. Financial Overview
    69. Products Offered
    70. Key Developments
    71. SWOT Analysis
    72. Key Strategies
    73. Roche Diagnostics
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. BioReference Laboratories
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Laboratory Corporation of America Holdings
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. Natera
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Agilent Technologies
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Myriad Genetics
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. Quest Diagnostics
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. andMe
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Fulgent Genetics
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Thermo Fisher Scientific
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Illumina
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Sema4
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. GeneDx
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. References
    152. Related Reports
    153. GCC Genetic Testing Market SIZE ESTIMATES & FORECAST, BY TYPE, 2019-2035 (USD Billions)
    154. GCC Genetic Testing Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    155. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    156. ACQUISITION/PARTNERSHIP
    157. MARKET SYNOPSIS
    158. GCC GENETIC TESTING MARKET ANALYSIS BY TYPE
    159. GCC GENETIC TESTING MARKET ANALYSIS BY APPLICATION
    160. KEY BUYING CRITERIA OF GENETIC TESTING MARKET
    161. RESEARCH PROCESS OF MRFR
    162. DRO ANALYSIS OF GENETIC TESTING MARKET
    163. DRIVERS IMPACT ANALYSIS: GENETIC TESTING MARKET
    164. RESTRAINTS IMPACT ANALYSIS: GENETIC TESTING MARKET
    165. SUPPLY / VALUE CHAIN: GENETIC TESTING MARKET
    166. GENETIC TESTING MARKET, BY TYPE, 2024 (% SHARE)
    167. GENETIC TESTING MARKET, BY TYPE, 2019 TO 2035 (USD Billions)
    168. GENETIC TESTING MARKET, BY APPLICATION, 2024 (% SHARE)
    169. GENETIC TESTING MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    170. BENCHMARKING OF MAJOR COMPETITORS

    GCC Genetic Testing Market Segmentation

    • Genetic Testing Market By Type (USD Billion, 2019-2035)

      • Molecular Genetic Tests/ DNA Tests
      • Chromosomal Genetic Tests
      • Biochemical Genetic Tests
      • Others

    • Genetic Testing Market By Type (USD Billion, 2019-2035)

      • Prescribed Genetic Testing
      • Direct-to-Consumer Genetic Testing

    • Genetic Testing Market By Application (USD Billion, 2019-2035)

      • Reproductive Health
      • Cancer Screening Ancestry
      • Predictive and Pre-Symptomatic Testing
      • Others
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027